Nuvo Group announced that it has received 510(k) clearance from the FDA to market INVU, a wearable device that remotely monitors fetal and maternal heart rates.
Fetal and maternal heart rates are important measurements late in pregnancy, and an elevated fetal heart rate can be one of the first signals of fetal distress. Currently, obtainin (Read more...)